ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,245, issued on March 11, was assigned to Northeastern University (Boston).

"Selectivity screening for antimicrobial compounds" was invented by Kim Lewis (Newton, Mass.), Anthony D'Onofrio (Northborough, Mass.), Thomas Curtis (Boston) and Charlotte Berkes (Melrose, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Assays for compounds having a desired biological activity against one but not both of a pair of microorganism species utilize separately detectable labels. The first and second microorganisms are different from each other, the first microorganisms exhibit a first detectable label, the second microorganisms exhibit a second detectable la...